How common is the CCR5 mutation?
Geneticists say that the CCR5 delta 32 mutation existed as many as 2,500 years ago, but back then it likely occurred in only 1 in 20,000 Europeans, as compared to 1 in 10 today. They believe that some viral disease provided the selection pressure needed to increase the frequency of the mutation.
What caused the CCR5 delta 32 mutation?
The origin of CCR5-Delta 32 and the reason of why only such selective group of Europeans carry this mutation has now been a topic of discussion. When it was first discovered, scientists believed that the bubonic plague, also known as the Black Death (1346-50 approx.), was the answer to the mutation.
Is CCR5 delta 32 hereditary?
In humans, the CCR5 gene that encodes the CCR5 protein is located on the short (p) arm at position 21 on chromosome 3. Certain populations have inherited the Delta 32 mutation, resulting in the genetic deletion of a portion of the CCR5 gene….CCR5.
| RNA expression pattern | |
|---|---|
| BioGPS | n/a |
Who has CCR5?
1. Introduction. Human CC-type chemokine receptor 5 (CCR5) is a member of the G-protein-coupled receptor (GPCR) family and is found predominantly on the cell surface of certain leukocytes, e.g. T cells, monocytes and macrophages [1].
Who has the CCR5 delta 32 mutation?
The mutation is found principally in Europe and western Asia, with higher frequencies generally in the north. Homozygous carriers of the Delta32 mutation are resistant to HIV-1 infection because the mutation prevents functional expression of the CCR5 chemokine receptor normally used by HIV-1 to enter CD4+ T cells.
What gene makes you immune to plague?
At present, scientists are trying to infect such resistant cells with bubonic plague bacteria to test the hypothesis that the mutation in the CCR-5 receptor gene could have thwarted the plague in the Middle Ages, as it does HIV today.
Are humans immune to the Black Death?
Scientists examining the remains of 36 bubonic plague victims from a 16th century mass grave in Germany have found the first evidence that evolutionary adaptive processes, driven by the disease, may have conferred immunity on later generations of people from the region.